IP Verse

Intervet International B.v. competitive analysis

Latest oppositions filed by Intervet International B.v.

Explore patent oppositions filed by Intervet International B.v. against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP3576785
Virus-Like Particle (Vlp)PHARMAQNov 19, 2025
EP3148576
Vaccine Composition Against Streptococcus Suis InfectionCEVA SANT ANIMALEJul 27, 2021
EP3344289
Pestivirus Vaccines For Congenital TremorsBOEHRINGER INGELHEIMOct 28, 2020
EP2873733
Vectors For Transforming Mycoplasma Hyopneumoniae, Transformed M. Hyopneumoniae Strains, And Use ThereofHIPRA SCIENTIFICMar 26, 2020
EP2785374
Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses ThereofHRINGSep 30, 2019
EP2998315
Newcastle Disease Virus Vectored Avian VaccinesHRINGJul 10, 2019
EP2931741
Porcine Parvovirus 5A, Methods Of Use And VaccineBOEHRINGER INGELHEIMApr 23, 2019
EP2992897
Immunogenic Compositions Comprising Lawsonia IntercellularisBOEHRINGER INGELHEIMApr 2, 2019
EP1968630
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsBOEHRINGER INGELHEIMOct 23, 2018
EP2957284
Animal Pest Control MethodE I DU PONT DE NEMOURSOct 17, 2018

Latest patents of Intervet International B.v. opposed by its competitors

Explore Intervet International B.v.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3471766
Jul 22, 2026Recombinant Non-Pathogenic Marek'S Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus And Infectious Bursal Disease Virus Antigens1
EP2268308
May 6, 2026Vaccine For Protection Against Lawsonia Intracellulars1
EP3185899
Jan 14, 2026Improved Hvt-Vectored Nd-Ibd Vaccine2
EP4008329
Jun 11, 2025Isoxazoline Compounds For Use In Treating Demodicosis2
EP2658542
Jun 4, 2025Topical Localized Isoxazoline Formulation1
EP3236960
Jan 29, 2025Use Of Isoxazoline Compounds For Treating Demodicosis2
EP2833866
Nov 27, 2024Soft Chewable Pharmaceutical Products2
EP3707128
Dec 20, 2023Injectable Isoxazoline Pharmaceutical Compositions And Their Use Against Parasite Infestation1
EP4153133
Nov 8, 2023Injectable Pharmaceutical Compositions And Uses Thereof1
EP2688587
Aug 16, 2023Salmonid Alphavirus Vaccine1

Latest PTAB cases involving Intervet International B.v.

Discover the latest PTAB cases involving Intervet International B.v., highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Intervet International B.v. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INTERVET124341
BOEHRINGER INGELHEIM3318789
CEVA SANTE ANIMALE235 - -
VIRBAC17 - - 1